Respiratory Syncytial Virus Symptomatic Fraction, Shedding and Detection in Children Aged 6-23 Months in South Africa in 2022.

Publication date: Sep 01, 2026

Accurate detection of RSV infections is important to understand epidemiology. We estimated symptomatic fraction and shedding duration of reverse-transcription polymerase chain reaction (RT-PCR)-confirmed cases and compared RSV detection through molecular and serologic techniques. We enrolled healthy children aged 6-23 months in a prospective cohort study, from May to October 2022, collecting thrice-weekly mid-turbinate nasal swabs for RSV RT-PCR testing. We collected serum at baseline and end of follow-up and detected anti-RSV IgG using enzyme-linked immunosorbent assay (ELISA) and multipathogen bead-based immunoassay (MIA). We ascertained symptoms by twice-weekly nurse visits, and daily caregiver symptom diaries. We calculated sensitivity, specificity, and positive (PPV) and negative (NPV) predictive value of RT-PCR, ELISA, and MIA compared to a standard (two or more assays-positive) among children with paired sera and baseline blood preceding an RT-PCR-confirmed episode. The RSV season started mid-February 2022. We enrolled 93 participants; 87 (94%) followed to the final study visit. Forty individuals had one or more RT-PCR-confirmed RSV infection, and six of them had a repeat episode. One-or-more symptom was reported from 54% (25/46) of RT-PCR-confirmed episodes, fever in 26% (12/46), and cough in 37% (17/46). Median RNA shedding duration was 7 days (IQR = 4-11 days). Among 80 children meeting criteria, ELISA and MIA each had > 92% sensitivity, specificity, PPV, and NPV while RT-PCR had 78% (95% CI = 61%-90%) sensitivity, 98% (95% CI = 88-100%) specificity, 97% (95% CI = 82%-100%) PPV, and 84% (95% CI = 71%-93%) NPV. Approximately half of RSV episodes were symptomatic. Serology had a high sensitivity and specificity for infection identification.

Open Access PDF

Concepts Keywords
Antibodies, Viral
Antibodies, Viral
burden
Enzyme-Linked Immunosorbent Assay
Female
Humans
Immunoglobulin G
Immunoglobulin G
Infant
Male
Prospective Studies
respiratory syncytial virus
Seasons
Sensitivity and Specificity
South Africa
South Africa
symptoms
transmission
vaccine
Virus Shedding

Semantics

Type Source Name
disease MESH RSV infections
drug DRUGBANK Palivizumab
disease MESH fever
disease MESH cough
disease MESH infection

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *